Intellia Therapeutics
8 followers
‌
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Industries
Headquarters
Employees
Links
Org chart
John Leonard
President & CEO
John Leonard
Collapse
Eliana Clark
EVP, CTO
David Lebwohl
EVP, Chief Medical Officer
Derek Hicks
EVP, Chief Business Officer
Laura Sepp-Lorenzino
EVP, Chief Scientific Officer
Edward Dulac
EVP & CFO
Michael Dube
Vice President, Chief Accounting Officer
Marika St. Amand
SVP, Chief Human Resources Officer
James Basta
EVP, General Counsel & Corporate Secretary
Aron Stein
SVP, Regulatory Affairs
Mary Ferguson
Senior Vice President, Head of Intellectual Property
Yuanxin Xu
SVP, Early Development & Transitional Medicine
Maria Natale
SVP, Commercial
Ray Kelley
Vice President Of Financial Planning Analysis
Emily Williams
Director Corporate Communications
Similar companies
AxoGen
1 follower
Thermo Fisher Scientific
150 followers
Genentech
146 followers
Natera
12 followers
10X Genomics
12 followers
Bruker
5 followers
Iovance Biotherapeutics
3 followers
Arrowhead Pharmaceuticals
3 followers
Verve Therapeutics
54 followers
Recursion Pharmaceuticals
7 followers
BioAgilytix
1 follower
Discover companies